Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources Research Institute of Science & Technology (CRRI) serves as the central innovation and R&D hub for the China Resources Group, a leading state-owned conglomerate in China. Based in the Guangdong-Hong Kong-Macao Greater Bay Area, the institute focuses on high-tech sectors including life sciences, health sciences, new materials, and microelectronics. In the healthcare domain, CRRI operates specialized research centers dedicated to cell and gene therapy, mRNA technology, and the modernization of traditional Chinese medicine. The institute acts as a bridge between academic research and industrial application, collaborating with top-tier universities and the Hong Kong Science and Technology Parks to drive the group's industrial transformation. Its efforts support the broader portfolio of China Resources Pharmaceutical, facilitating the development of innovative therapeutics and medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Resources Research Institute of Science & Technology.